Open Orphan - £6.2m Influenza human challenge study contract win

Mo Khan, Chief Executive Officer of Open Open Orphan plc, a rapidly growing specialist contract research organisation and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan plc, has signed a £6.2m Influenza human challenge study contract.

Yamin 'Mo' Khan
Chief Executive Officer

Company Events - OPEN ORPHAN